Retatutride
Retatutride - 40mg Pen
Retatrutide 40mg is a GLP-1, GIP, and glucagon metabolic-support weight-management product designed to support appetite control, satiety, food-intake regulation, metabolic support, energy-use support, and progressive body-composition improvement.
Retatrutide works around GLP-1, GIP, and glucagon metabolic-support pathways, making it the advanced option in Meytrix Therapeutics weight-management range for structured fat-loss and body-composition protocols.
This product includes one Retatrutide 40mg reconstituted for use in the Meytrix Therapeuticals reusable or disposable pen system. It is intended for structured once-weekly dosing, with gradual escalation based on tolerance and response.
Each Pen includes:
- 1 x Retatrutide 40mg Peptide Pen
- 8 x pen needles
This product is supplied in a disposable pen l. The reusable pen kit is sold separately.
How It Works
Retatrutide is positioned as the strongest metabolic-support option in the Meytrix Therapeutics weight-management range, using triple-pathway support for appetite regulation, satiety, food-intake control, metabolic signalling, and energy-use support.
Its activity is positioned around three key metabolic-support pathways involved in hunger control, fullness after meals, metabolic regulation, and energy expenditure.
Primary Support Areas
- Appetite control: supports reduced hunger and food cravings.
- Satiety support: supports improved fullness after meals.
- Food-intake control: supports lower calorie intake through improved hunger regulation.
- Metabolic support: supports structured fat-loss progression over time.
- Energy-use support: supports increased energy expenditure and body-composition improvement.
Retatrutide is a metabolic-regulation protocol. It is not a structural repair peptide.
Results and Outcomes
Retatrutide is used where the objective is stronger appetite control, improved dietary consistency, and more reliable fat-loss progress over time.
It may be used as part of protocols focused on:
- Reduced hunger
- Improved satiety
- Lower food intake
- Better dietary control
- Metabolic regulation
- Stronger fat-loss support
- Progressive weight-management support
- Body-composition improvement over time
Expected Outcomes
| Expected Outcome | Practical Effect |
|---|---|
| Reduced appetite | Supports less hunger through the day. |
| Improved satiety | Supports easier portion control. |
| Lower food intake | Supports improved calorie control. |
| Better dietary adherence | Supports improved consistency with a structured eating plan. |
| Progressive fat-loss support | Supports ongoing body-composition improvement over time. |
Dosage Protocol
Product Format
- Product contents: 1 x Retatrutide Pen 40mg
- Needles included: 8 x pen needle
- Reusable pen kit: sold separately
Per Cartridge
- Strength: 40mg / 3mL
- Concentration: 15mg/mL
- Pen system: 200 clicks per cartridge
- Per click: 0.15mg
- Per click volume: 0.01mL
- Administration: once weekly unless using the higher split-dose format
Click Calculation
- 40mg ÷ 3mL = 15mg/mL
- 40mg ÷ 200 clicks = 0.15mg per click
- 3mL ÷ 200 clicks = 0.01mL per click
Dose Reference
| Clicks | Dose | Volume | Use |
|---|---|---|---|
| 5 clicks | 0.75mg | 0.05mL | Low reference dose |
| 10 clicks | 1.5mg | 0.10mL | Weeks 1–4 |
| 15 clicks | 2.25mg | 0.15mL | Intermediate reference dose |
| 20 clicks | 3.0mg | 0.20mL | Weeks 5–8 |
| 25 clicks | 3.75mg | 0.25mL | Intermediate reference dose |
| 30 clicks | 4.5mg | 0.30mL | Weeks 9–12 |
| 35 clicks | 5.25mg | 0.35mL | Split-dose reference |
| 40 clicks | 6.0mg | 0.40mL | Weeks 13–16 |
| 50 clicks | 7.5mg | 0.50mL | Maintenance reference |
| 60 clicks | 9.0mg | 0.60mL | Higher-range reference |
Escalated Split-Dose Reference
| Schedule | Total Weekly Clicks | Total Weekly Dose | Total Weekly Volume |
|---|---|---|---|
| 35 clicks twice weekly | 70 clicks | 10.5mg | 0.70mL |
| 40 clicks twice weekly | 80 clicks | 12.0mg | 0.80mL |
Recommended Dosage
Retatrutide Refill Cartridge 40mg is administered once weekly unless using the higher split-dose format.
| Phase | Frequency | Clicks | Dose | Volume |
|---|---|---|---|---|
| Weeks 1–4 | Once weekly | 10 clicks | 1.5mg | 0.10mL |
| Weeks 5–8 | Once weekly | 20 clicks | 3.0mg | 0.20mL |
| Weeks 9–12 | Once weekly | 30 clicks | 4.5mg | 0.30mL |
| Weeks 13–16 | Once weekly | 40 clicks | 6.0mg | 0.40mL |
| Maintenance reference | Once weekly | 50 clicks | 7.5mg | 0.50mL |
| Higher-range reference | Once weekly | 60 clicks | 9.0mg | 0.60mL |
| Higher split-dose option | Twice weekly | 35 clicks per dose | 10.5mg total weekly | 0.70mL total weekly |
| Maximum split-dose option | Twice weekly | 40 clicks per dose | 12.0mg total weekly | 0.80mL total weekly |
Cycle Structure
- Use once weekly according to the structured escalation protocol.
- Do not inject more than once weekly unless using the higher split-dose format.
- At higher ranges, split the weekly dose evenly into twice-weekly administrations.
- Do not increase the dose if the current dose is not well tolerated.
- Dose escalation should be gradual and based on tolerance.
- Use as part of a structured weight-management plan that includes dietary control, hydration, and consistent lifestyle habits.
- A 50-click dose is commonly used as a practical maintenance reference because it provides approximately 6 weeks of treatment from one cartridge.
- Some users may require a lower or higher maintenance reference depending on response, tolerance, and weight-management goals.
Notes
- This product is a single refill pen cartridge.
- Product includes 1 x Retatrutide 40mg refill pen cartridge and 8 x pen needle.
- Reusable pen kit is sold separately.
- Store refrigerated at 2–8°C.
- Do not freeze.
- Administer subcutaneously using the Meytrix pen system.
- Common administration areas include the abdomen, thigh, or upper arm.
- Rotate administration sites.
- Use once weekly unless following the higher split-dose format.
- Higher doses should only be used once lower doses are well tolerated.
- Retatrutide Refill Cartridge Pen 40mg is the single-cartridge format in Meytrix Therapeutics weight-management range.
- Retatrutide is a metabolic-regulation protocol and is not a structural repair peptide.
Warnings
- Not suitable for people under the age of 18.
- Not suitable during pregnancy.
- Not suitable while breastfeeding.